Global Nerve Repair and Regeneration Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

Clear

Description

Global Nerve Repair and Regeneration Market: Market Segments: By Product (Neurostimulation and Neuromodulation Devices, Biomaterials); By Application (Neurostimulation and Neuromodulation Surgeries, Diagnostics, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy); By End User (Hospitals, Ambulatory Surgical Centers and Clinics); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030
Product Overview
Intricate and fragile spinal cord, peripheral nerves, and brain structures make the nervous system vulnerable to different forms of injuries. This results in illnesses that are neurodegenerative and causing devastating physical disabilities. The machines for nerve repair and regeneration help to facilitate the regeneration of peripheral nerves. Nervous system repair and regeneration is a process that helps damaged tissue to regrow and heal, leading to a prospective recovery of the function of the nervous system.
Market Highlights
Global Nerve Repair and Regeneration Market is expected to project a notable CAGR of XX.X% in 2030.
Global Nerve Repair and Regeneration Market to surpass USD XXXX million by 2030 from USD XXXX million in 2018 at a CAGR of XX% throughout the forecast period, i.e. 2019-30. The growth of the worldwide demand for nerve repair and regeneration can be due to rising geriatric population and a growing number of neurological disorders worldwide.
Global Nerve Repair and Regeneration Market: Segments
Biomaterials Segment to grow with the highest CAGR of XX.X% during 2019-30
Global Nerve Repair and Regeneration Market is segmented by product into neurostimulation and neuromodulation devices, and biomaterials. The greater market share in 2018 was accounted by Neurostimulation and neuromodulation devices segment and is expected to see the highest growth during the forecast period. In order to dominate the neurostimulation and neuromodulation devices segment during the forecast era. This segment’s significant market share is mainly driven by increasing government spending on neurological disorders and favorable reimbursements.

Global Nerve Repair and Regeneration Market: Market Dynamics
Drivers
High Incidence of Nerve Injuries
The primary factor driving the market for nerve repair and regeneration procedures is the high incidence of nervous system injuries. Due to factors such as high rate of nervous system injuries and nervous system reconstruction, enhanced effectiveness of biomaterials in the treatment of nervous system injuries, rise in incidence rate of chronic CNS disorders such as Alzheimer’s and Parkinson’s disease, ageing population, increased healthcare expenditure, new applications such as DBS and launching A significant growth driver for the industry is a rapid rise in the occurrence of neurological disorders and peripheral nerve injuries.
Restrain
Preference for Drug Therapies Over Nerve Repair and Regeneration Products
Some of the main factors restricting market growth are the lack of knowledge among patients and doctors about nerve repair and regeneration products and techniques, and the lack of trained practitioners.
Global Nerve Repair and Regeneration Market: Regions
Global Nerve Repair and Regeneration Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.
Global Nerve Repair and Regeneration Market in North America held the largest market share of XX.X% in the year 2018 owing to increased occurrence of neurological disorders in the area and a favourable health insurance coverage scenario. Also, involvement of major market players, the availability of technologically advanced devices is also a major factor for dominance of the region. Due to the rising target population base, rising awareness among patients, supportive government initiatives, the presence of unmet medical needs and the emergence of advanced technologies, Asia Pacific is the fastest growing region.
Global Nerve Repair and Regeneration Market: Key Players
• Synapse Biomedical, Inc.
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Medtronic, plc
• Boston Scientific Corporation
• Abbott Laboratories
• Axogen, Inc.
• Baxter International, Inc.
• Livanova, plc
• Integra Lifesciences
• Polyganics
• Neuropace, Inc.
• Soterix Medical, Inc.
• Nevro Corp
Global Nerve Repair and Regeneration Market report also contains analysis on:
Global Nerve Repair and Regeneration Market Segments:
Market Segmentation
By Product:
• Neurostimulation and Neuromodulation Devices
• Biomaterials
By Application:
• Nerve Grafting
• Neurostimulation & Neuromodulation Surgeries
• Direct Nerve Repair/Neurorrhaphy
• Stem Cell Therapy
By End User:
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Global Nerve Repair and Regeneration Market Dynamics
• Global Nerve Repair and Regeneration Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

1. Executive Summary
2. Global Nerve Repair and Regeneration Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Hospital Beds Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Nerve Repair and Regeneration Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. Global Nerve Repair and Regeneration Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe: (Brazil, Mexico, Argentina, Rest of Latin America)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. LATAM: (Brazil, South Africa, Saudi Arabia, U.A.E. and Other Countries)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. MEA: (Brazil, South Africa, Saudi Arabia, U.A.E. and Other Countries)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Neurostimulation & Neuromodulation Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Biomaterials, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3. By Application: Market Share (2020-2030F)
12.3.1. Neurostimulation & Neuromodulation Surgeries, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Direct Nerve Repair/Neurorrhaphy, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Stem Cell Therapy, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4. By End User: Market Share (2020-2030F)
12.4.1. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.2. Ambulatory Surgical Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.3. Clinics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13 Company Profile
13.1. Medtronic, plc
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Boston Scientific Corporation.
13.3. Abbott Laboratories
13.4. Axogen, Inc.
13.5. Baxter International, Inc
13.6. Zydus Cadila
13.7. Livanova, plc
13.8. Integra Lifesciences
13.9. Soterix Medical, Inc.
13.10. Other Prominent Players
14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.